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of salt restriction for stable heart failure, some studies suggest that low-sodium diets may increase activation of the renin-angiotensin-aldosterone system potentially translating into worse clinical outcomes.
The PROHIBIT (Prevent Adverse Outcomes in Heart
Failure by Limiting Sodium) study will evaluate adherence to different levels of sodium restriction and provide pilot data on the feasibility and design of a pivotal trial of dietary sodium intake (4).
In addition, although cardiac rehabilitation has been shown to be safe and have a modest effect on quality of life in patients with chronic heart failure, data for cardiac rehabilitation is limited to stable outpatients (5). Patients hospitalized for acute heart failure are phenotypically different than those with ambulatory heart failure and may lack the ability to participate in and/or derive a robust benefit from a structured aerobic exercise program. Thus, the role of cardiac rehabilitation after hospitalization for acute heart failure remains uncertain and is the focus Please note: Dr. Mentz has received research support from Amgen, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Gilead, Novartis, Otsuka, and ResMed; and has received honoraria from Thoratec. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
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